Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
crispr
life sciences
national
3
×
national blog main
national top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
celgene
crispr therapeutics
detroit blog main
detroit top stories
fda
gene editing
gene therapy
glaxosmithkline
indiana blog main
indiana top stories
intellia therapeutics
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
2025
ad-comm
affimed
akcea therapeutics
alector
alkermes
What
crispr
3
×
new
3
×
bio
cancer
known
roundup
allogene
biopharma
cas
cells
congress
congressional
defect
diversity
drive
edited
editing
executives
fears
feud
flag
gene
genetic
group
guardian
hot
human
immunotherapy
investors
ipo
isn’t
juno
lab
later
malfunction
medicine
million
month
nature
nearly
Language
Current search:
national
×
crispr
×
new
×
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells